Side-by-side comparison of AI visibility scores, market position, and capabilities
São Paulo neobank (NYSE: NU) world's largest digital bank at 114.2M customers; $11.5B revenue 2024 (58% YoY) with $2B net income and Mexico banking license 2025 competing with Itaú for LatAm consumer banking.
Nubank is a São Paulo, Brazil-based neobank and digital financial services platform — publicly traded on the New York Stock Exchange (NYSE: NU) at a $60+ billion market capitalization — providing digital banking, credit cards, personal loans, insurance, and investment products to 114.2 million customers across Brazil, Mexico, and Colombia as of Q4 2024, growing 22% year-over-year to become the world's largest digital bank by customer count. In 2024, Nubank reported $11.5 billion in revenue (58% year-over-year growth) and $2 billion in net income, demonstrating the profitability transition from growth-stage fintech to a scaled financial institution. In 2025, Nubank secured a full banking license in Mexico, enabling deposit-taking and expanded lending products in its second-largest market. Founded in 2013 by David Vélez, Cristina Junqueira, and Edward Wible in São Paulo.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.